FFG
HZNP

Fortem Financial Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Fortem Financial Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,141
Closed -$83K – 469
2020
Q4 		$83K Buy
+1,141
New +$84.8K 0.05% 191
2020
Q3 		– Sell
-4,318
Closed -$240K – 167
2020
Q2 		$240K Buy
+4,318
New +$185K 0.19% 107
2019
Q2 		– Sell
-7,659
Closed -$202K – 168
2019
Q1 		$202K Buy
+7,659
New +$181K 0.21% 118

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fortem Financial Group's HZNP Position: Q1 2021 in Review

Fortem Financial Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 1,141 shares — an estimated $83K sold.

Fortem Financial Group first reported a position in HZNP in Q1 2019 and held it in 3 quarters. The position peaked at $240K in Q2 2020. 516 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

  • Fortem Financial Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Fortem Financial Group sold 1,141 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $83K.
  • Fortem Financial Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 3 quarters.
  • Fortem Financial Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $240K in Q2 2020.
  • 516 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on Fortem Financial Group's 13F filing for Q1 2021, filed 20 Apr 2021.